Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
-
32 Years: Ryan White HIV/AIDS Program
August 18, 2022 marks the 32nd anniversary of the Ryan White HIV/AIDS Program.Blog updated 10/04/2022
-
Imagine: Ending HIV. It’s Possible.
Imagine: Ending HIV. It’s Possible is the name of a new, national campaign to encourage and energize the HIV workforce to achieve the national goal of ending the HIV epidemic.Blog updated 06/30/2022
-
Healthy Divas: E2i
Healthy Divas focuses on empowering transgender women with HIV to achieve their personal health goals. Three sites implemented the intervention as part of the E2i initiative funded through the RWHAP Part F SPNS program from 2017 through 2021. Both engagement in HIV care and having an antiretroviral therapy prescription improved significantly for clients 12 months after enrollment in Healthy Divas.Resource from the RWHAP Best Practices Compilation updated on 04/18/2024
-
National Monitoring Standards for RWHAP Part A Recipients
This HRSA technical assistance webinar was to provide a high level overview of updates made to the National Monitoring Standards (NMS). Release of the NMS is forthcoming.Resource updated 08/21/2023
-
RWHAP Part B/ADAP Coordination with Medicare
Review of the basic elements of the Medicare program and information to support RWHAP Part B/ADAP coordination with Medicare.Resource updated 10/05/2023
-
Text Me, Girl!: Transgender-Specific Text Messaging to Support Care Engagement
Ninetyday theory-based, transgender-specific, automated text-messaging intervention designed to improve engagement, retention, and health outcomes along the HIV care continuum.Resource updated 02/07/2024
-
Providing Gender-Affirming Care
Review of gender-affirming care issues, including key terminology, best practices in hormone therapy management, epidemiology of HIV in transgender populations, and strategies to improve HIV care and prevention in transgender communities.Resource (Conference Presentation) updated 09/14/2023
-
TransActivate
Bienestar developed TransActivate to improve timely engagement and retention in HIV care among Latina transgender women. Linkage coordinators/peer navigators use a strengths-based approach to help clients reach their goals of entering and staying in medical care to ultimately reach viral suppression.Resource from the RWHAP Best Practices Compilation updated on 02/12/2024
-
How to Conduct Remote Subrecipient Site Visits
Best practices and tools for conducting effective remote subrecipient monitoring. Presentation from the HRSA HIV/AIDS Bureau Division of State HIV/AIDS Programs (DSHAP) Business Day Meeting at the 2022 RWC.Resource (Conference Presentation) updated 09/14/2023
-
Text Me, Girl!
Text Me, Girl! is a text messaging intervention that aims to improve linkage to and retention in HIV care, increase adherence to HIV medications, and improve viral suppression and other health outcomes among transgender women ages 18–34 years. The intervention supports young transgender women with HIV, particularly those experiencing barriers to care such as periods of homelessness and/or incarceration, substance misuse, or engaging in sex work. Text Me, Girl! participation was associated with statistically significant improvements in antiretroviral therapy uptake and adherence, and self-reported viral suppression.Resource from the RWHAP Best Practices Compilation updated on 04/01/2024
-
After Hours Drop-In Clinic
Howard Brown Health established a specialized drop-in clinic and support groups, and implemented organizational initiatives to provide culturally relevant and gender-affirming services for transgender and non-binary people, including transgender women of color. The goal of this intervention was to optimize engagement in HIV services and primary care. From 2012-2021, the number of transgender and non-binary people served in primary care at Howard Brown Health more than tripled. In addition, after 24 months, participants were more likely to have been prescribed ART and to be virally suppressed than at baseline.Resource from the RWHAP Best Practices Compilation updated on 02/20/2024
-
Women Informing Now: A Two-Year Retrospective Reducing Isolation and Stigma among Women of Color with HIV
Two-year retrospective exploring innovative approaches to reduce stigma and isolation among cis and transgender women of color with HIV, including women with HIV residing in rural areas not connected to care.
Resource (Conference Presentation) updated 09/14/2023
-
Are We There Yet? Fine-tuning Your Budget Navigation System
Framework for effective financial management and compliance with HRSA HAB National Fiscal Monitoring Standards, including timely decision-making and other features.
Resource (Conference Presentation) updated 09/14/2023
-
Long-acting Injectable HIV Treatment Implementation and Coordination
Overview of the policies, procedures, and protocols developed by an ADAP and Part C clinic to establish access to antiretrovirals, including long-acting cabotegravir/rilpivirine.
Resource (Conference Presentation) updated 09/14/2023
-
Providing Gender-Affirming Care to People with HIV
Overview of the gender-affirming care and treatment services available through the RWHAP and The Fenway Institute.
Resource (Conference Presentation) updated 09/14/2023
-
Replicating Evidence-Informed Interventions: Toolkit Showcase from the E2i Initiative
Overview of RWHAP SPNS E2i Initiative implementation materials.
Resource (Conference Presentation) updated 09/14/2023
-
Plenary: Innovation (Ending the HIV Epidemic, National HIV/AIDS Strategy)
Applying the HIV/AIDS Bureau implementation science framework; trauma-informed care in dental settings; and review of an organization's status-neutral approach to care .
Resource (Conference Presentation) updated 09/14/2023
-
RWHAP Program Letter: ADAPs and SUD Medications
On May 11, HRSA’s HIV/AIDS Bureau released a program letter encouraging RWHAP ADAP recipients to include medications for SUDs, including buprenorphine for OUD, and naloxone for opioid overdose prevention, on ADAP formularies.News Article updated on 05/15/2023 -
PEP Efficacy for Chlamydia, Gonorrhea
Doxycycline that is taken as post-exposure prophylaxis (PEP) is effective in reducing the incidence of chlamydia and gonorrhea in men who have sex with men and transgender women.News Article updated on 04/11/2023